10x Genomics (TXG) 10-Q2021 Q2 Quarterly report

Filed: 6 Aug 21, 4:05pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. senior Avg

New words: accustomed, compatible, Delta, FFPE, managerial, MHC, paused, placement, ramp, redesign, situation, variant, VAT, water, zoning

Removed: account, accrual, accused, accusing, actively, addressing, affirmed, affirming, al, allege, allocating, alternatively, antitrust, appeal, appealed, assay, assessment, ATAC, attempting, August, back, barcoding, barring, battle, BD, bead, bear, Biosafety, cease, cellular, Chicago, chip, Circuit, Clayton, CNV, conclusion, conferencing, constitute, counsel, covenant, ddSEQ, DE, defendant, deposited, desist, determination, dismissed, droplet, entry, escrow, estimable, evidentiary, exclusion, execution, exempted, fee, filtering, found, front, fundamentally, gel, harmful, Harvard, implicate, imported, importing, independently, inflow, informed, infringed, initial, injunction, instituted, institution, inter, IPR, isolate, issuable, ITC, joined, judge, jury, justifiable, Lawrence, leveraged, lift, liquid, Livermore, LLC, loosening, Markman, milestone, molecular, monopolizing, moved, Munich, Northern, obligated, October, oral, original, pendency, percent, phone, plaintiff, pre, preliminary, presence, presidential, presiding, preventing, Profiling, projected, protective, proximity, PTAB, Purifying, Raindance, recall, recalled, recognizing, reconsider, recording, recovery, refiled, refrain, refundable, regain, Regional, remanded, remedial, renewed, represented, request, Respiratory, resurgence, ruled, safeguard, segregated, Sherman, stage, stay, stayed, staying, Stilla, supplemental, symptom, tariff, test, thirty, title, track, transmission, treble, trial, uncovered, unfair, University, unlicensed, unspecified, utilizing, vacated, validated, verdict, version, video, vigorously, violation, virtual, weekly, William, Young

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

Associated TXG transcripts

TXG similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, I, Justin J. McAnear, the Chief Financial Officer of 10x Genomics, Inc. (the “Company”), hereby certify, that, to my knowledge:

1.The Quarterly Report on Form 10-Q for the period ended June 30, 2021 (the “Report”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


Date: August 6, 2021	By:	/s/ Justin J. McAnear
		Justin J. McAnear Chief Financial Officer (Principal Financial and Accounting Officer)